scholarly journals Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market

2020 ◽  
Author(s):  
Aljoscha Janssen
Keyword(s):  
Switching Costs ◽  
Pharmaceutical Market ◽  
Behavioral Pricing

Reduction in Switching Costs for Difficult Tasks With Task Priming

2004 ◽  
Author(s):  
Padmanabhan Sudevan ◽  
John Holmes ◽  
Amber Corry ◽  
Jeffrey Willems ◽  
Marisa Hoffman ◽  
...  
Keyword(s):  
Switching Costs

Glembotskaya G.T., Eremin S.Yu. Scientific and practical approach to optimizing costs on development and promotion of drugs

2019 ◽  
Vol 2019 (3) ◽  
pp. 47-53
Author(s):  
Галина Глембоцкая ◽  
Galina Glembockaya ◽  
Станислав Еремин ◽  
Stanislav Eremin
Keyword(s):  
Scientific Literature ◽  
Pharmacological Action ◽  
Pharmaceutical Market ◽  
Pharmaceutical Companies ◽  
Strategic Development ◽  
The World ◽  
The Russian Federation ◽  
The Cost ◽  
Further Development ◽  
Registration Phase

In order to identify promising strategic development possibilities for the pharmaceutical industry in the Russian Federation, a pilot study was conducted, which has analyzed the main trends in the development of innovative medicines. As a result of the content analysis of available sources of scientific literature, the characteristics of options used in the world practice for increasing the innovative activity of individual subjects and the pharmaceutical market as a whole are presented. Possible reserves for the further development of the innovative component of the pharmaceutical market within the framework of the concept of personalized medicine according to the P4 principle (predictive - personalized - preventive - participatory) are identified and structured. The results of use by individual pharmaceutical companies of scientifically and practically justified approaches to optimizing the costs of development and promoting drugs are presented. The advantages and real prospects of a generally accepted method to reduce the cost of development by «expanding the pharmacological effect» (label expansion) of already existing drugs with a known safety profile in the world practice are shown. A scientific generalization and structuring of the goals and results of the post-registration phase of clinical trials to expand the pharmacological action of a number of drugs already existed at the market have been carried out.

The influenced factors of bilinguals' language switching costs

2017 ◽  
Vol 25 (9) ◽  
pp. 1469
Author(s):  
Xin CHANG ◽  
He BAI ◽  
Pei WANG
Keyword(s):  
Switching Costs ◽  
Language Switching
Sign in / Sign up

Export Citation Format

Share Document